University College London Hospitals

What University College London Hospitals does

University College London Hospitals NHS Foundation Trust is a publicly funded NHS Foundation Trust providing acute and specialist healthcare services across seven hospital sites in central London. The trust operates University College Hospital, the Grafton Way Building (haematology and cancer), Westmoreland Street (cardiac and outpatient), the Royal National ENT Hospital, the Eastman Dental Hospital, the National Hospital for Neurology and Neurosurgery, and the Royal London Hospital for Integrated Medicine, serving both a local London population and national specialist referrals. Headcount is reported at 10,000+ employees, with leadership under Chief Executive David Probert and a board chaired by Baroness Julia Neuberger.

The trust runs an active research and clinical trials portfolio that includes proton beam therapy, CAR T-cell therapies, and experimental cellular immunotherapies. In October 2025 UCLH became the first UK site to perform a Neuralink brain-computer interface implant, and the same month the trust dosed the first UK patient in the Phase 1 BOBCAT trial of obecabtagene autoleucel for progressive multiple sclerosis, and treated the first UK patient with CAR T-cell therapy for multiple sclerosis. It also published a 40-year longitudinal Sjögren's disease study identifying lymphoma risk predictors.

Commercially, UCLH's revenue model is dominated by NHS commissioning contracts underwritten by UK taxation, supplemented by private patient services via the UCLH Private Healthcare sub-brand, income from pharmaceutical and biotech-sponsored clinical trials (including partnerships with Neuralink and Autolus Therapeutics), and charitable donations through UCLH Charity, Friends of UCLH, and The EGA Hospital Charity. As an NHS Foundation Trust it is a not-for-profit public benefit corporation, not publicly traded, and revenue figures are not publicly disclosed. The trust is closely affiliated with University College London as its academic teaching partner and participates in the UCLPartners academic health science network and the London Sarcoma Service with the Royal National Orthopaedic Hospital.

Name

University College London Hospitals

Legal name

University College London Hospitals NHS Foundation Trust

Website

https://uclh.nhs.uk

Company type

Private

Founded year

1834

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

University College London Hospitals NHS Foundation Trust is a publicly funded NHS Foundation Trust operating seven specialist hospitals in central London, delivering acute and specialist care, advanced oncology and neuroscience services, and clinical trials to NHS patients, private patients and research partners.

Ownership category

akta.pro rank

Product category

Acute Hospital Services

NAICS

General Medical and Surgical Hospitals (62211), General Medical and Surgical Hospitals (6221)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Hospitals (8060)

akta.pro primary industry

Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)

Keywords

• Acute hospital services
• Specialist healthcare
• Cancer treatment
• Clinical research
• Private healthcare

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices7 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain

Revenue model

1. NHS Core Funding: Core funding from the UK National Health Service for providing acute and specialist healthcare services to the population of London and beyond.
2. Private Healthcare Services: Revenue generated from private patient care through UCLH Private Healthcare, offering specialist treatment options to self-pay and insured patients.
3. Clinical Research and Trials: Funding from pharmaceutical companies and research councils for conducting clinical trials and medical research, including partnerships with companies like Autolus Therapeutics and Neuralink.
4. Charitable Donations: Charitable contributions through UCLH Charity supporting various hospital services, arts programs, and patient care initiatives.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

Core offering

UCLH NHS Foundation Trust provides comprehensive acute and specialist healthcare services across five hospitals in central London, including cancer care, neurology and neurosurgery, cardiac services, haematology, ENT, dental, and emergency services. The trust combines clinical care with groundbreaking medical research, hosting clinical trials with biotechnology companies and offering private healthcare services alongside NHS-funded care free at the point of use.

Product overview

University College London Hospitals NHS Foundation Trust provides a comprehensive range of acute and specialist healthcare services through multiple hospital sites in central London. The trust operates as an integrated hospital system offering services including cancer care (medical oncology, haematology, radiotherapy, proton beam therapy, surgical oncology), cardiac services, neurology and neurosurgery, children's and young people's services, emergency and critical care, diagnostic imaging, dental services, and numerous medical specialties. The trust's service portfolio encompasses clinical treatment, diagnostic services, rehabilitation, and support services delivered through specialized departments and units across its hospital sites.

Differentiator

Problem solved

Functional benefit

Brands

• UCLH Arts: Arts and heritage program integrated into the hospital environment, featuring exhibitions, commissions, and creative workshops for patients and staff.
• UCLH Private Healthcare
• Macmillan Cancer Centre
• Grafton Way Building

Products and services

• UCLH Private Healthcare
• Clinical Trials and Medical Research
• University College Hospital Services
• National Hospital for Neurology and Neurosurgery
• Royal National ENT Hospital
• Eastman Dental Hospital
• Royal London Hospital for Integrated Medicine
• UCH Macmillan Cancer Centre
• Grafton Way Building

Quantifiable outcome

• 9.9% lymphoma development rate identified over 40-year period in Sjögren's patients
• +2 more outcomes

Named customers3 records

Segments8 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• NeuralinkcoreStrategic or Co-development Partner · 28 October 2025Neuralink, Elon Musk's neurotechnology company, partnered with UCLH to conduct the first successful brain chip implant in the UK. The procedure at UCLH enabled a paralyzed patient with motor neuron disease to control a computer through thought, marking an expansion of Neuralink's human trials to the UK.
• Autolus TherapeuticscoreStrategic or Co-development Partner · 20 October 2025Autolus Therapeutics partnered with UCLH NHS Foundation Trust to conduct the Phase 1 BOBCAT trial of obecabtagene autoleucel (Obe-Cel) for progressive multiple sclerosis. UCLH dosed the first patient in this trial evaluating safety, tolerability, and preliminary efficacy in up to 18 adult patients with refractory PMS.
• UCLPartnerscoreStrategic or Co-development PartnerUCLPartners is an academic health science partnership that UCLH works with for research collaboration, innovation, and healthcare improvement initiatives across London.
• Friends of UCLH CharityminorOthersThe Friends of University College London Hospitals is a charitable organization supporting UCLH through fundraising and patient support initiatives.
• Macmillan Cancer SupportcoreStrategic or Co-development PartnerMacmillan Cancer Support partners with UCLH to provide the Macmillan Support and Information Service, offering cancer patients access to support specialists, welfare advice, and information resources. UCLH has received the Macmillan Quality Environment Mark.
• University College London (UCL)coreStrategic or Co-development PartnerUCLH is closely affiliated with University College London as a teaching hospital, collaborating on research, clinical trials, and medical education. UCL academics serve as clinical leaders within the trust.
• London Sarcoma Service PartnerscoreStrategic or Co-development PartnerThe London Sarcoma Service is a partnership between UCLH and Royal National Orthopaedic Hospital (RNOH), providing specialist sarcoma diagnosis, treatment, and research across multiple sites.
• Global CAR T-cell Therapy Trial PartnerscoreStrategic or Co-development PartnerUCLH participated in a global clinical trial for CAR T-cell therapy for multiple sclerosis, treating the first UK patient with this experimental immunotherapy approach that aims to reset the immune system.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• The Christie NHS Foundation Trust: UK's largest single-site specialist cancer hospital, Europe's first proton beam therapy centre, and a major clinical trials hub. Direct peer for UCLH's cancer, proton beam, and CAR T-cell programmes.
• Barts Health NHS Trust: UK's largest NHS trust operating five hospitals across East London with academic affiliation to Queen Mary University of London. Comparable multi-site operating model and broad specialist portfolio.
• Cambridge University Hospitals NHS Foundation Trust: Addenbrooke's is one of the UK's foremost academic health science centres, closely integrated with the University of Cambridge. Directly comparable as a research-intensive teaching hospital trust outside London.
• Imperial College Healthcare NHS Trust: London academic health science centre operating multiple hospital sites and deeply integrated with Imperial College London. Directly comparable to UCLH as a research-intensive multi-site London teaching trust.
• Royal Marsden NHS Foundation Trust: UK specialist cancer hospital and clinical trials centre with the Royal Marsden/ICR biomedical research axis. Directly comparable for oncology depth, trial activity, and Macmillan partnership.
• Guy's and St Thomas' NHS Foundation Trust: Major London teaching hospital trust with similar scale, academic affiliation (King's College London), and full-spectrum specialist services. The most direct comparable peer for UCLH within London, competing for specialist referrals and research grants.
• Oxford University Hospitals NHS Foundation Trust: Oxford's main NHS teaching trust with deep University of Oxford research ties, specialist services across oncology, neurosciences, and clinical trials. Closely comparable academic-NHS operating model.
• King's College Hospital NHS Foundation Trust: Large South London teaching hospital with significant specialist services (neurosciences, liver, haematology) and academic ties to King's College London. Closely comparable specialist portfolio and case mix to UCLH.
• Royal Free London NHS Foundation Trust: London teaching hospital trust with academic affiliation to UCL itself, providing specialist services including transplantation and infectious diseases. Comparable inner-London teaching trust footprint.

Emerging players

• Great Ormond Street Hospital for Children NHS Foundation Trust: Specialist paediatric NHS trust and major paediatric clinical trials centre co-located with UCL Institute of Child Health. Comparable as a specialist NHS trust embedded in an academic campus with significant research activity.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/uclh
• YouTubeyoutube.com/user/UCLHNHS
• Facebookfacebook.com/uclhnhs
• LinkedInlinkedin.com/company/uclh-nhs-foundation-trust
• Instagraminstagram.com/uclh

Revenue estimate

Valuation estimate

Number of profiles

Profiles21 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about University College London Hospitals